Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Akash Mathavan, Akshay Mathavan, Mohit Mathavan, Urszula Krekora, Aaron J Winer, Ellery Altshuler, Russell Wnek, Keegan Hones, Arushi Thaper, Richard Artola, Logan Pucci, Patrick Haley, Del Carter, William Snead, Denise Manfrini, Daniel F. Leach$suffix/text()$suffix/text(), Jess D DeLaune & Molly W Mandernach. (2023) Impact of genotype on clinical course in sickle cell disease and the utility of neutrophil-lymphocyte ratio: a ten-year single-institution experience. Expert Review of Hematology 16:9, pages 701-710.
Read now
Read now
Tagwa Yousif Elsayed Yousif. (2022) Impact of Abnormal Leukocyte Count in the Pathophysiology of Sickle Cell Anemia. Journal of Blood Medicine 13, pages 673-679.
Read now
Read now
Articles from other publishers (50)
Jessica M F Oliveira, Gabriela S Arcanjo, Igor F Domingos, Jéssica V G F Batista, Diego A Pereira-Martins, Thais H C Batista, Betânia L D Hatzlhofer, Diego A Falcão, Madi V Diniz, Alexsandro P Silva, Bárbara C V Pires, Ana C dos Anjos, Fernando F Costa, Aderson S Araujo, Antonio R Lucena-Araujo & Marcos A Bezerra. (2024) A-296G variant of THBS1 gene (rs1478605) is associated with a lower frequency of stroke in a Brazilian population with sickle cell anemia. Journal of Stroke and Cerebrovascular Diseases 33:1, pages 107474.
Crossref
Crossref
Rachel G. Sinkey, Foluso J. Ogunsile, Julie Kanter, Cynthia Bean & Mara Greenberg. (2023) Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology.
Crossref
Crossref
Mustapha Dibbasey, Mamudou Dahaba, Francess Sarfo, Ida Jallow-Manneh, Buntung Ceesay, Solomon Umukoro, Mouhamadou Fadel Diop & Alfred Amambua-Ngwa. (2023) Laboratory indices of hospitalized sickle cell disease patients, prevalence and antimicrobial susceptibility of pathogenic bacterial isolates at MRCG ward in the Gambia. BMC Infectious Diseases 23:1.
Crossref
Crossref
Abhishek Gour, Dilpreet Kour, Ramajayan Pandian, Mahir Bhardwaj, Sanghapal D. Sawant, Ajay Kumar & Utpal Nandi. (2023) Ellagic Acid Exerts Dual Action to Curb the Pathophysiological Manifestations of Sickle Cell Disease and Attenuate the Hydroxyurea-Induced Myelosuppression in Berkeley Mice. ACS Pharmacology & Translational Science 6:6, pages 868-877.
Crossref
Crossref
Patrick B. Walter, Leah S. Hohman, Andrew Rokeby, Julian J. Lum, Robert Hagar, Lisa Lavrisha, Augusta Saulys, Frans A. Kuypers, Elliott Vichinsky & Claudia R. Morris. (2022) The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells. Complementary Therapies in Medicine 70, pages 102856.
Crossref
Crossref
Susanna A. Curtis, Balbuena-Merle Raisa, John D. Roberts, Jeanne E. Hendrickson, Joanna Starrels, Devine Lesley, DeVeaux Michelle, Zelterman Daniel & Amanda M. Brandow. (2022) Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy. Transfusion and Apheresis Science 61:2, pages 103304.
Crossref
Crossref
Mohamed E. Suliman, Mohammed G. A. Ansari, Mohamed A. Rayis, Muaawia A. Hamza, Abdullah A. Saeed, Abdul Khader Mohammed & Nasser M. Al-Daghri. (2021) Telomere length and telomere repeat-binding protein in children with sickle cell disease. Pediatric Research 91:3, pages 539-544.
Crossref
Crossref
Qinhong Wang & Rahima Zennadi. (2021) The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications. Antioxidants 10:10, pages 1608.
Crossref
Crossref
Hanan Kifah Abdul-Hussein, Hind Shaker Al-Mammori & Meaàd Kadhum Hassan. (2021) Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients. Cytokine 143, pages 155534.
Crossref
Crossref
Talal Qadah, Abdulwahab Noorwali, Fatma Alzahrani, Alaa Banjar, Najlaa Filimban & Raed Felimban. (2020) Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia. Indian Journal of Hematology and Blood Transfusion 36:4, pages 705-710.
Crossref
Crossref
Madhan Thamilarasan, Rodolfo Estupinan, Ines Batinic-Haberle & Rahima Zennadi. (2020) Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo. Blood Advances 4:11, pages 2372-2386.
Crossref
Crossref
Igor F. Domingos, Diego A. Pereira-Martins, Marcondes J. V. C. Sobreira, Romulo T. D. Oliveira, Adekunle E. Alagbe, Carolina Lanaro, Dulcineia M. Albuquerque, Maria H. S. L. Blotta, Aderson S. Araujo, Fernando F. Costa, Antonio R. Lucena-Araujo, Maria F. Sonati, Marcos A. C. Bezerra & Magnun N. N. Santos. (2020) High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia. Annals of Hematology 99:5, pages 947-953.
Crossref
Crossref
Samuel N. Uwaezuoke. (2020) Acute Chest Syndrome in Children with Sickle Cell Disease: Current Perspectives on Pathogenesis and Treatment. EMJ Hematology, pages 42-51.
Crossref
Crossref
Ann Brunson, Theresa Keegan, Anjlee Mahajan, Richard White & Ted Wun. (2019) High incidence of venous thromboembolism recurrence in patients with sickle cell disease. American Journal of Hematology 94:8, pages 862-870.
Crossref
Crossref
Ibrahim S. Tuna, Bedirhan Tarhan, Mauricio Escobar & Mehmet S. Albayram. (2019) T2-blackout effect on DWI as a sign of early bone infarct and sequestration in a patient with sickle cell disease. Clinical Imaging 54, pages 15-20.
Crossref
Crossref
Kavita Rana, Kimberly Pantoja & Liping Xiao. (2018) Bone marrow neutrophil aging in sickle cell disease mice is associated with impaired osteoblast functions. Biochemistry and Biophysics Reports 16, pages 110-114.
Crossref
Crossref
Mohsen Saleh ElAlfy, Amira Abdel Moneam Adly, Fatma Soliman ElSayed Ebeid, Deena Samir Eissa, Eman Abdel Rahman Ismail, Yasser Hassan Mohammed, Manar Elsayed Ahmed & Aya Sayed Saad. (2018) Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy. Immunologic Research 66:4, pages 480-490.
Crossref
Crossref
Ali AlJama, Mohammed AlKhalifah, Ibrahim Abdulla Al-Dabbous & Ghada Alqudaihi. (2018) Vitamin D deficiency in sickle cell disease patients in the Eastern Province of Saudi Arabia. Annals of Saudi Medicine 38:2, pages 130-136.
Crossref
Crossref
Halima W. M. Al Balushi, David C. Rees, John N. Brewin, Anke Hannemann & John S. Gibson. (2018) The effect of xanthine oxidase and hypoxanthine on the permeability of red cells from patients with sickle cell anemia. Physiological Reports 6:5, pages e13626.
Crossref
Crossref
Cyril Martin, Vincent Pialoux, Camille Faes, Emmanuelle Charrin, Sarah Skinner & Philippe Connes. (2018) Does physical activity increase or decrease the risk of sickle cell disease complications?. British Journal of Sports Medicine 52:4, pages 214-218.
Crossref
Crossref
Shilpa JainNitya BakshiLakshmanan Krishnamurti. (2017) Acute Chest Syndrome in Children with Sickle Cell Disease. Pediatric Allergy, Immunology, and Pulmonology 30:4, pages 191-201.
Crossref
Crossref
Ankit A. DesaiZhengdeng LeiNeil BahroosMark Maienschein-ClineSantosh L. SarafXu ZhangBinal N. ShahSeyed M. Nouraie, Taimur AbbasiAmit R. Patel, Roberto M. Lang, Yves LussierJoe G. N. GarciaVictor R. GordeukRoberto F. Machado. (2017) Association of circulating transcriptomic profiles with mortality in sickle cell disease. Blood 129:22, pages 3009-3016.
Crossref
Crossref
Susanna A. Curtis, Neeraja Danda, Zipora Etzion, Hillel W. Cohen & Henny H. Billett. (2016) Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease. PLOS ONE 11:10, pages e0164743.
Crossref
Crossref
Amira A. Adly, Eman A. Ismail, Nevine G. Andrawes, Mai M. Mahmoud & Rasha Eladawy. (2016) Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease. Cytokine 79, pages 52-58.
Crossref
Crossref
S. Voskou, M. Aslan, P. Fanis, M. Phylactides & M. Kleanthous. (2015) Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biology 6, pages 226-239.
Crossref
Crossref
Jorge Delgado, Maria A. Bedoya, Abby M. Green, Diego Jaramillo & Victor Ho-Fung. (2015) Utility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease — can it differentiate bone infarcts from acute osteomyelitis?. Pediatric Radiology 45:13, pages 1981-1987.
Crossref
Crossref
Susanna A. Curtis, Neeraja Danda, Zipora Etzion, Hillel W. Cohen & Henny H. Billett. (2015) Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia. PLOS ONE 10:8, pages e0133116.
Crossref
Crossref
Kyung Hee Chang, Ramesh C Nayak, Swarnava Roy, Ajay Perumbeti, Ashley M Wellendorf, Katie Y Bezold, Megan Pirman, Sarah E Hill, Joseph Starnes, Anastacia Loberg, Xuan Zhou, Tadashi Inagami, Yi Zheng, Punam Malik & Jose A Cancelas. (2015) Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT2R and cytoskeletal dysregulation. Nature Communications 6:1.
Crossref
Crossref
Rahima Zennadi. (2014) MEK Inhibitors, Novel Anti-Adhesive Molecules, Reduce Sickle Red Blood Cell Adhesion In Vitro and In Vivo, and Vasoocclusion In Vivo. PLoS ONE 9:10, pages e110306.
Crossref
Crossref
Rafael Ramos da Silva, Michelly Cristiny Pereira, Moacyr Jesus Barreto Melo Rêgo, Betania Lucena Domingues Hatzlhofer, Aderson da Silva Araújo, Marcos André Cavalcanti Bezerra, Ivan da Rocha Pitta & Maira Galdino da Rocha Pitta. (2014) Evaluation of Th17 related cytokines associated with clinical and laboratorial parameters in sickle cell anemia patients with leg ulcers. Cytokine 65:2, pages 143-147.
Crossref
Crossref
Martha M. Arruda, Grazielle Mecabo, Celso A. Rodrigues, Sandra S. Matsuda, Iara B. Rabelo & Maria S. Figueiredo. (2012)
Antioxidant vitamins
C
and
E
supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double‐blind, placebo‐controlled trial
. British Journal of Haematology 160:5, pages 688-700.
Crossref
Crossref
Erfan Nur, Bart J. Biemond, Hans‐Martin Otten, Dees P. Brandjes & John‐John B. Schnog. (2011) Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. American Journal of Hematology 86:6, pages 484-489.
Crossref
Crossref
Julia E. Brittain, Ben HulkowerSusan K. JonesDell StrayhornLaura De Castro, Marilyn J. Telen, Eugene P. OrringerAlan Hinderliter & Kenneth I. Ataga. (2010) Placenta growth factor in sickle cell disease: association with hemolysis and inflammation. Blood 115:10, pages 2014-2020.
Crossref
Crossref
Cara Rosenbaum, David Peace, Elizabeth Rich & Koen Van Besien. (2008) Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease. Biology of Blood and Marrow Transplantation 14:6, pages 719-723.
Crossref
Crossref
Michael S. Isakoff, J. Alyssa Lillo & J. Nathan Hagstrom. (2008) A Single-Institution Experience With Treatment of Severe Acute Chest Syndrome: Lack of Rebound Pain With Dexamethasone Plus Transfusion Therapy. Journal of Pediatric Hematology/Oncology 30:4, pages 322-325.
Crossref
Crossref
Efemwonkiekie W. Iyamu, Chiazotam Ekekezie & Gerald M. Woods. (2007)
In vitro
evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes
. British Journal of Haematology 139:2, pages 337-343.
Crossref
Crossref
Gail DallalioChris Y. BrunsonRobert T. MeansJrJr. (2023) Cytokine Concentrations in Bone Marrow of Stable Sickle Cell Anemia Patients. Journal of Investigative Medicine 55:2, pages 69-74.
Crossref
Crossref
Kyoung S. Kim, Vikram Rajagopal, Caryn Gonsalves, Cage Johnson & Vijay K. Kalra. (2006) A Novel Role of Hypoxia-Inducible Factor in Cobalt Chloride- and Hypoxia-Mediated Expression of IL-8 Chemokine in Human Endothelial Cells. The Journal of Immunology 177:10, pages 7211-7224.
Crossref
Crossref
Maria Augusta Arruda, Pedro Barcellos-de-Souza, André Luiz Franco Sampaio, Adriano G. Rossi, Aurélio V. Graça-Souza & Christina Barja-Fidalgo. (2006) NADPH oxidase-derived ROS: Key modulators of heme-induced mitochondrial stability in human neutrophils. Experimental Cell Research 312:19, pages 3939-3948.
Crossref
Crossref
Matthew C. Wagner, James R. Eckman & Timothy M. Wick. (2005) Histamine increases sickle erythrocyte adherence to endothelium. British Journal of Haematology 0:0, pages 051220012327005.
Crossref
Crossref
Iris D. Buchanan, Maribel Woodward & George W. Reed. (2005) Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatric Blood & Cancer 45:5, pages 716-724.
Crossref
Crossref
J. B. Schnog, T. Teerlink, F. P. L. van der Dijs, A. J. Duits & F. A. J. Muskiet. (2004) Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Annals of Hematology 84:5, pages 282-286.
Crossref
Crossref
J.A.B. Chies, C. Dresch, M.S. Cruz, G. da Silva, E. Barros, C. Bittar, J. Friedrisch & L.M.R. Silla. (2005) Immunosuppressive therapy for kidney transplant prevents vaso-occlusive crisis in a haemoglobin SC disease patient. Medical Hypotheses 64:1, pages 174-176.
Crossref
Crossref
Maria Augusta Arruda, Adriano G. Rossi, Marta S. de Freitas, Christina Barja-Fidalgo & Aurélio V. Graça-Souza. (2004) Heme Inhibits Human Neutrophil Apoptosis: Involvement of Phosphoinositide 3-Kinase, MAPK, and NF-κB. The Journal of Immunology 173:3, pages 2023-2030.
Crossref
Crossref
J. David Holtzclaw, Daniel Jack, Samuel M. Aguayo, James R. Eckman, Jesse Roman & Lewis L. Hsu. (2004) Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice. American Journal of Respiratory and Critical Care Medicine 169:6, pages 687-695.
Crossref
Crossref
Heather J. Zar. (2004) Etiology of sickle cell chest. Pediatric Pulmonology 37:S26, pages 188-190.
Crossref
Crossref
Suresh K. SelvarajRanjit K. GiriNatalya PerelmanCage JohnsonPunam MalikVijay K. Kalra. (2003) Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102:4, pages 1515-1524.
Crossref
Crossref
Natalya PerelmanSuresh K. SelvarajSandeep BatraLori R. LuckAnat Erdreich-EpsteinThomas D. CoatesVijay K. KalraPunam Malik. (2003) Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 102:4, pages 1506-1514.
Crossref
Crossref
Neil M. MatsuiAjit VarkiStephen H. Embury. (2002) Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 100:10, pages 3790-3796.
Crossref
Crossref
TED WUN, MIGUEL CORDOBA, ARUN RANGASWAMI, ANTHONY W. CHEUNG & TERESA PAGLIERONI. (2002) Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*. Clinical and Laboratory Haematology 24:2, pages 81-88.
Crossref
Crossref